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Abstract
Background: Cutaneous basal cell carcinoma (BCC) is the commonest cancer worldwide. BCC is locally invasive and
the surrounding stromal microenvironment is pivotal for tumourigenesis. Cancer associated fibroblasts (CAFs) in the
microenvironment are essential for tumour growth in a variety of neoplasms but their role in BCC is poorly understood.
Methods: Material included facial BCC and control skin from the peritumoural area and from the buttocks. With
next-generation sequencing (NGS) we compared mRNA expression between BCC and peritumoural skin. qRT-PCR,
immunohistochemical and immunofluorescent staining were performed to validate the NGS results and to investigate
CAF-related cyto-and chemokines.
Results: NGS revealed upregulation of 65 genes in BCC coding for extracellular matrix components pointing at
CAF-related matrix remodeling. qRT-PCR showed increased mRNA expression of CAF markers FAP-α, PDGFR-β and
prolyl-4-hydroxylase in BCC. Peritumoural skin (but not buttock skin) also exhibited high expression of PDGFR-β and
prolyl-4-hydroxylase but not FAP-α. We found a similar pattern for the CAF-associated chemokines CCL17, CCL18,
CCL22, CCL25, CXCL12 and IL6 with high expression in BCC and peritumoural skin but absence in buttock skin.
Immunofluorescence revealed correlation between FAP-α and PDGFR-β and CXCL12 and CCL17.
Conclusion: Matrix remodeling is the most prominent molecular feature of BCC. CAFs are present within BCC stroma and
associated with increased expression of chemokines involved in tumour progression and immunosuppression (CXCL12,
CCL17). Fibroblasts from chronically sun-exposed skin near tumours show gene expression patterns resembling that of CAFs,
indicating that stromal fibroblasts in cancer-free surgical BCC margins exhibit a tumour promoting phenotype.
Background
Basal cell carcinoma (BCC) of the skin is the most frequent
cancer worldwide and the incidence is increasing [1]. BCC
is locally invasive and the microenvironment surrounding
BCC is crucial for the tumourigenesis, which was empha-
sised by auto-transplantation experiments where human
BCC failed to grow in the absence of stroma [2]. In particu-
lar, fibroblasts in the surrounding tumour stroma seem es-
sential for a variety of neoplasms [3, 4]. These cancer
associated fibroblasts (CAFs) are characterised by a distinct
activated phenotype and by expression of a variety of
markers, such as fibroblast activated protein-α (FAP-α) and
platelet-derived growth factor receptor β (PDGRF-β) [3].
Production of extracellular matrix components and cyto-
kine secretion are some of the mechanism induced by CAF
to promote tumour growth [5]. The role of CAFs has been
widely investigated in breast cancer where they promote
tumour growth via interaction with neoplastic cells [5].
Interestingly, not only CAFs within or immediately adjacent
to tumour but also CAFs from cancer-free tissue adjacent
to tumour exhibited tumour-promotion [6]. Cross-talk
between BCC and CAFs and related matrix-remodeling is
suggested [7] but this has not been extensively studied.
With this study we show, by the use of next-generation
sequencing (NGS), that the most predominant genes
expressed in BCC are involved in matrix remodeling. The
findings of CAFs also in the peritumoural skin suggest
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CAFs to mediate an environment susceptible to skin can-
cer development and recurrence.
Methods
Material
The study was approved by the Danish Regional Ethics
Committee, protocol number: H-4-2013-197 and the Danish
Data Protection Agency, journal number: BBH-2014-008, I-
Suite: 02675. All participants gave signed informed consent.
Material consisted of facial BCC and peritumoural skin
obtained during Mohs surgery and 4 mm punch biopsies
from the buttock collected at the Department of Derma-
tology, Bispebjerg University Hospital, Denmark. All
BCCs were clinically nodular BCCs. The peritumoural
skin was taken after complete removal (microscopically
verified) of cancerous tissue. For qRT-PCR we included
skin from 18 patients (Table 1) from BCC, peritumoural
skin and buttock skin. Since the RNA yield was lower
for the buttock skin, not all qRT-PCR analyses could be
performed for this group. For each analysis, the exact
number of buttock samples is mentioned in the figure
legend. Material for immunohistochemical staining was
taken from the same samples as the ones for qRT-PCR
by splitting the material in two and embedding half for
immunohistochemistry in Tissue-Tek (Sakura, Leiden,
Netherlands) while immediately freezing the other half
for qRT-PCR in −80 °C until analysis. For NGS we in-
cluded BCC and peritumoural skin from additional four
patients taken during Mohs surgery and snap frozen at
−80 °C until analysis.
Quantitative real-time PCR (qRT-PCR)
The frozen skin material (BCC, peritumoral skin and but-
tock skin) including both the dermal and epidermal part,
that was frozen until qRT-PCR analysis, was thawed in
RNA later (Sigma, St. Louis MO, USA) and minced into
1 mm pieces. The method was performed as described
previously [8]. All analyses were run as triplicates. The
primer-probes used were: GAPDH (HS02758991_g1), IL6
(HS00985639_m1), CD3 (HS00174158_m1), CXCL12
(HS03676656_mH), CXCR4 (HS00607978_s1), CCL11
(HS_00237013_m1), CCL17 (HS00171074_m1), CCL18
(HS00268113_m1), CCL22 (HS01574247_m1), CCL25
(HS00608373_m1), PDGFRβ (HS01019589_m1), FAP-α
(HS00990806_m1), Collagen 11A (HS01097664_m1) and
P4HA2 (HS00990001_m1). The data obtained from
CC17, CCL18, and CCL22 analyses have previously been
published together with data on T-regs [8]. Obtained data
were analysed by the ΔΔCT method [9, 10] with GAPDH
as housekeeping reference gene.
Immunohistochemistry and immunofluorescence
For immunohistochemical staining, 10 μm sections were
cut from the embedded tissue blocks on a Microm HM560
cryostat and mounted on glass slides for immunohisto-
chemical and immunofluorescent stainings. For 3,3′-Diami-
nobenzidine (DAB) (Dako, Glostrup, Denmark) stainings,
the sections were fixed using acetone at -20o C for 10 min.
Endogenous peroxidase activity was quenched using 0.3%
H2O2 (Merck, Millipore, Darmstadt, Germany) in PBS for
15 min at room temperature (RT) in the dark. The sections
Table 1 Baseline characteristics of the included patients
Sample no Age Ethnic origin Tumor size, mm Anatomic localisation
1 70–74 Caucasian 6×6 Temporal region
6 65–69 Caucasian 6×14 Cheek
7 65–69 Caucasian 7×8 Glabella
8 50–54 Asian 4×4 Nose
10 45–49 Caucasian 6×6 Nose
13 45–49 Caucasian 16×18 Cheek
15 70–75 Caucasian 4×4 Nose
20 55–59 Caucasian 7×7 Nose
23 70–74 Caucasian 7×10 Nose
24 60–64 Caucasian 10×17 Temporal region
29 45–49 Caucasian 11×11 Nose
30 50–54 Caucasian 5×5 Nose
35 75–79 Caucasian 22×22 Temporal region
36 70–74 Caucasian 10×14 Forehead
37 70–74 Caucasian 10×10 Cheek
38 80–84 Caucasian 10×18 Eyebrow
39 70–74 Caucasian 8×8 Nose
41 55–59 Caucasian 8×11 Cheek
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were blocked in 10% horse serum (Gibco, Fisher Scientific,
New Zealand) and 1% bovine serum albumin (BSA) (Sigma,
St. Louis MO, USA) in PBS for 1 h at RT and followed by
incubation with the primary antibody (rabbit anti-FAP-α
(1:100, LS-C313051, LSBio, Seattle, USA), mouse anti-
CXCL12 (1:40, MAB350, R & D systems, Oxon, UK), rabbit
anti-Collagen 11A (1:100, ab64883, Abcam, Cambridge,
UK), rabbit anti-CXCR4 (1:400, AHP442, AbD Serotec, Ox-
ford, UK), rabbit anti-IL6 (1:600, ab6672, Abcam), rabbit
anti-PDGFRβ (1:100, LS-C312148, LSBio), mouse anti-
CCL17 (1:80, LS-C198166, LSBio), mouse anti-CCL22
(1:100, MAB336, R & D systems) or rabbit anti-P4HA2
(1:80, LS-C91131, LSBio)) diluted in 1%BSA in PBS over
night at 4 °C. Incubation with secondary antibody (goat
anti-rabbit HRP (1:200, P0448, Dako), goat anti-mouse
HRP (1:200, P0447, Dako)) diluted in 10% horse serum and
1% BSA in PBS for 40 min at RT was performed. DAB was
added to visualise the staining and the sections were incu-
bated with haematoxylin for 1 min followed by coverslip-
ping with glycergel mounting medium (Dako).
For immunofluorescence (IF) stainings, sections were
fixed and blocked as described above (peroxidase quench-
ing step was omitted) followed by incubation with combi-
nations of two primary antibodies (rabbit anti-FAP-α
(1:200, LS-C313051, LSBio), mouse anti-CCL17 (1:80, LS-
C198166, LSBio) PCGFR-β (1:100, LS-C312148, LSBio),
CXCL12 (1:40, MAB350, R & D systems, Oxon, UK),
CCL22 (1:100, MAB336, R & D systems)) diluted in block-
ing solution overnight at 4 °C. Incubation with secondary
antibodies (goat anti-rabbit Alexa568 (1:500, A11036, Life
Technologies) and/or goat anti-mouse Alexa488 (1:500,
A11001, Life Technologies, Thermo Fischer Scientific)) di-
luted in 1% BSA in PBS was then performed for 1 h at RT
in the dark. This was followed by incubation with 0.5 μg/
ml 4′,6-Diamino-2-phenylindole (DAPI) (Sigma) and cov-
erslipping with glycergel mounting medium.
Transcriptome sequencing
Large RNAs were extracted and isolated from the samples
using the NucleoSpin® miRNA kit [11] following the proto-
col for purification of small and large RNA in separate frac-
tions but skipping the DNA digestion step. The frozen
tissue samples were cut into smaller pieces on dry ice,
transferred to lysis buffer containing two stainless steel
beads of 2–3 mm in diameter, and homogenised using the
TissueLyser II (Quiagen, Hilden, Germany) prior to extrac-
tion. For each sample, 5 μl extract were DNase treated for
30 min at 37° with 1 μl TURBO DNase enzyme (Thermo-
Fisher, www.thermofisher.com) in a total volume of 50 μl.
The RNA was subsequently purified using the RNeasy
MinElute Cleanup Kit (Quiagen). Libraries were prepared
from 100 ng of RNA, using the ScriptSeq v2 RNA-Seq
Library Preparation kit (Epicentre, Illumina, www.illumina
.com), following the manufacturer’s guidelines, and with
12 cycles of PCR amplification. Paired-end sequencing of
100 base pairs was performed on the Illumina HiSeq 2000
platform, yielding more than 380 million paired-end
sequence reads (Additional file 1: Table S1). Removal of
adapters, quality trimming and merging of paired reads was
carried out using open-source AdapterRemoval software
[12]. Reads were mapped onto the human genome (assem-
bly version hg19) using the RNA-seq aligner RNAstar [13].
Potential PCR duplicate reads were discarded using the
rmdup function in samtools [14]. Whereas approximately
97% of all reads mapped to the human genome, duplicate
reads constituted a significant fraction leaving only around
48 million unique reads (Additional file 1: Table S1). From
this mapping, transcript abundance was estimated running
FLUX CAPACITOR [15] provided with the GENCODE
gene annotation [16]. The raw number of reads assigned to
each transcript by FLUX CAPACITOR was used as input
for EdgeR (Version 3.2, Bioconductor) [17].
Statistical analysis
Statistical analyses were performed by unpaired Students
t-test (normal distributed data) or Mann-Whitney U test
(non-normal distributed data) using GraphPad Prism 4
(GraphPad software Inc., CA, USA). Statistical significance
was set at P < 0.05.
The NGS data were analysed following estimation of
dispersions, and genes differentially expressed between
BCC and peritumoural skin were tested using the Exact-
Test function in EdgeR.
Results
mRNA expression analysis with NGS identifies remodeling
of extracellular matrix in BCC
Analysis of mRNA expression was investigated by RNA
sequencing, revealing upregulation of 542 genes in BCC,
for number of reads see Additional file 1: Table S1. Of
these, 65 genes were coding for extracellular matrix com-
ponents or enzymes involved in matrix metabolism such
as metalloproteinases (Additional file 2: Table S2) like
WNT1-inducible-signaling pathway protein 1 (WISP-1),
extracellular matrix protein 1, and matrix metallopepti-
dases (European Nucleotide Archive (http://www.ebi.a-
c.uk/ena), accession PRJEB12664). The expression pattern
reflected the hallmarks of matrix remodeling seen in
other cancer types, such as overexpression of lysol
oxidase-like 2 (LOXL2), fibronectin, proteoglycans, fac-
tors involved in epithelial to mesenchymal transition
such as lymphoid enhancer binding factor (LEF) [18–20]
and αVβ6-integrin and collagen types VI and XI not nor-
mally encountered in skin [21]. Overexpression of prolyl-
4-hydroxylase (P4H) and (PDGFR-β) in BCC pointed at a
high level of CAFs.
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Identification of CAFs in BCC and peritumoural skin
CAFs are recognised by the expression of several
markers including FAP-α, PDGFR-β and P4H [22, 23].
Genes from the latter two markers were found upregu-
lated in our mRNA expression analysis. For validation of
the NGS data and further investigation, the mRNA levels
of FAP-α, PDGFR-β and P4H as well as collagen XIA in
BCC, peritumoural skin and normal, non-UV exposed
buttock skin were evaluated by the use of qRT-PCR. For
most genes a consistent expression pattern was observed
with the highest expression of CAF markers within
BCC, followed by peritumoural skin and very low or no
expression in the normal buttock skin (Fig. 1). FAP-α ex-
pression was only seen within BCC.
To identify the localisation of the CAFs we performed
immunohistochemical staining for FAP-α, PDGFR-β, P4H
and Collagen XIA. FAP-α, collagen XIA, P4H and
PDGFR-β positive cells were highly abundant within the
BCC tumour islands and in the near tumour periphery.
Staining of the peritumoural skin also revealed FAP-α, col-
lagen XIA, P4H and PDGFR-β positive cells, although not
as numerous as in BCC. In the normal buttock skin, we
identified a smaller amount of PDGFR-β and P4H positive
cells in the epidermis but no collagen XIA or FAP-α posi-
tive cells (Fig. 2).
CAFs are a source cytokines and chemokines involved in
tumour progression and local immunosuppression
Apart from the role in the synthesis of aberrant matrix
components, CAFs can modulate the tumour microenvir-
onment by producing chemokines and cytokines affecting
the anti-tumour immune response [3, 7]. We performed
qRT-PCR to detect the chemokine and cytokine mRNA
levels in BCC, peritumoural-and buttock skin for the fol-
lowing genes: IL6, CXCL12, CCL17, CCL18, CCL22 and
CCL25. These genes were selected since previous studies
have pointed to them being involved in CAF-mediated
tumour progression [6, 24, 25] or to the ability of these
chemokines to attract regulatory T-cells (T-regs) [26–28].
For all cytokines and chemokines investigated, we found a
high expression in BCC and/or peritumoural skin and
barely any in the buttock skin (Fig. 3).
Fig. 1 mRNA expression levels of CAF-markers and collagen XI in BCC, peritumoral skin and buttock skin. Gene expression of PDGRF-β, FAP-α,
P4H and collagen XIA mRNA by qRT-PCR in BCC tumour (T), n = 18 (PDGFR-β, P4H), n = 17 (FAP-α, collagen XIA), peritumoural skin (P), n = 18,
and buttock (B), n = 12 (PDGFR-β, P4H), n = 11 (FAP- α), n = 7 (collagen XIA). Significance level * = p < 0.5, ** = p < 0.001, *** = p < 0.0001.
Where no *, no statiscally significant difference detected
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CXCL12, CCL17 and CCL22 play a role in the recruit-
ment of T-regs to tumour sites and thereby inhibition of
anti-tumour response [26–28]. We have previously shown
an increased T-reg accumulation in relation to BCC7 and
this led us to investigate a correlation between CAFs and
T-reg attraction. IF double staining of FAP-α/CXCL12,
FAP-α/CCL17, FAP-α/CCL22, as well as PDGFR-β/
CCL17 and PDGFR-β/CCL22 were performed.The IF
stainings indicated correlation between FAP-α/CXCL12
and FAP-α/CCL17 as well as PDGFR-β/CCL17 (Fig. 4),
whereas no correlation was found between CCL22 and
CAF markers. These findings support the hypothesis that
CAFs mediate tumour progression by production of the
T-reg chemotaxis CCL17 and CXCL12.
Discussion
It is becoming evident that cancer development is
dependent not only on neoplastic cells but is co-mediated
by the tumour microenvironment [29]. For many cancer
types, CAFs are essential contributors to tumour progres-
sion [3, 6]. The role of CAFs in BCC has not been investi-
gated in detail. Lacina et al. suggested that fibroblasts
from BCC play a regulatory role in BCC since they were
capable of influencing growth and phenotype of normal
cultured keratinocytes [30]. Our study provide further
support to the concept that CAFs are involved in patho-
genesis of BCC. We found increased expression of CAF-
associated markers within BCC as well as in the peritu-
moural cancer-free tissue in contrast to absence of CAF-
markers in the normal, non-UV exposed buttock skin.
The mRNA expression of FAP-α was specific to BCC
highlighting a pivotal role of FAP-α expressing CAFs in
the development of BCC. The expression of PDGFR-β
and P4H positive cells was found both within BCC as well
as in the peritumoural cancer-free skin surrounding BCC.
This indicates, as is the case for breast cancer [6], that
Fig. 2 Immunohistochemical staining for CAF-markers and collagen XI. The photos show numerous positively stained cells in BCC, some in the
peritumoural skin and few or none in the normal buttock skin of PDGRF-β, FAP-α, collagen XIA and (magnification ×20)
Omland et al. BMC Cancer  (2017) 17:675 Page 5 of 9
fibroblasts in peritumoural skin exhibit a specific gene ex-
pression pattern intermediate between those of CAFs in
BCC and normal fibroblasts (from buttock skin).
CAF-mediated tumour progression is exerted in many
ways with chemokine and cytokine secretion being an es-
sential contributor. In pancreatic cancer, CAF-induced
IL6 secretion promotes cancer cell migration [24] and
CAF-secreted CCL18 has been shown to promote tumour
invasion in breast and ovarian cancer [25, 31]. Further-
more, CCL25 can mediate migration, invasion and matrix
metalloproteinase expression in breast cancer cell lines
[32]. With this study we found increased expression of
CCL18 and CCL25 in BCC and peritumoural skin sup-
porting a role for these chemokines in the pathogenesis of
BCC. Increased IL-6 expression was found primarily in
the peritumoural skin suggesting an impact of IL6 mainly
in the peritumoural skin and a possible correlation to
PDGRF-β and P4H, but not FAP-α expressing CAFs. This
predominance of IL6 in the peritumoural surroundings is
supported by a previously described role for IL-6 in medi-
ating epithelial to mesenchymal transition [33].
Hindering the entry of T-cells into tumours or inactivat-
ing them could additionally be a CAF-mediated contributor
to ineffective anti-tumour immune surveillance. CXCL12 is
a chemokine causing direct immunosuppression via immo-
bilisation of T-cells [32]. CXCL12 has been extensively
studied and shown to be released by CAFs causing prema-
lignant activities in tumour cells and in the cells of the
tumour milieu [34, 35]. We found a high expression of
CXCL12 in the peritumoural skin but low expression
within BCC highlighting a role for CXCL12 primarily in the
tumour microenvironment surrounding BCC. Accumula-
tion of T-regs via CAF- secreted chemokines could also be
orchestrated to avoid anti-tumour response. CXCL12,
CCL22 and CCL17 have been described as critical factors
for T-reg attraction in different cancer types [36, 37]. We
have previously shown increased fraction of T-regs within
BCC and in the peritumoural skin [8]. With this study, we
demonstrate a possible correlation between CAFs and
CXCL12 and CCL17 supporting the hypothesis of CAFs
being involved in T-reg attraction. However, this possible
correlation was demonstrated by IF only, and further stud-
ies are needed to understand mutual regulatory relation-
ships between T-regs and CAFs.
Apart from increased CAF expression in relation to BCC,
our study also demonstrated features of matrix remodeling
with an important contributor being overexpression of
collagen XI. Overexpression of this collagen has been
shown to promote tumour progression and to be associated
with poor outcome in many cancer types and is suggested
as a target for future cancer therapy [21, 38]. To our
knowledge, the presence of collagen XI in BCC has not
Fig. 3 Gene expression of cytokine and chemokine mRNA by qRT-PCR. The mRNA expression levels of the cytokines CCL17, CCL18, CCL22,
CCL25, and CXCL12 in BCC and peritumoural skin reveals increased expression in BCC and peritumoral skin whereas there is no expression in the
normal non UV-exposed buttock skin. BCC tumour (T), n = 18 for all markers except CCL25 n = 17); peritumoural skin (P), n = 18 for all markers,
and buttock (B), n = 18 (CXCL12), n = 16 (CCL17), n = 14 (CCL18), n = 12 (CCL22), n = 11 (CCL25). Significance level * = p < 0.5, ** = p < 0.001,
*** = p < 0.0001. Where no *, no statiscally significant difference detected
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previously been described. Our results clearly demonstrate
increased collagen XI expression primarily within BCC but
also in the peritumoural cancer-free tissue. In the normal
buttock skin however, collagen XI expression was com-
pletely absent. Collagen XI has been assigned a metastatic
potential for other cancer types [39]. BCC rarely metasta-
sises and the abundance of this collagen within BCC might
be an important mediator of local invasive growth. This,
however, needs further investigation.
The tumour seed and soil hypothesis claims that for a
tumour to grow, the microenvironment has to be sus-
ceptible [40]. Most reports claim CAFs to be initiated by
tumour cells but there is evidence that CAFs are acti-
vated at an early stage contributing to tumour initiation
[41]. The phenotype of the CAFs in the tumour-near
skin intermediate between CAFs in BCC and fibroblasts
in the normal skin could be mediated through secreted
molecules able to diffuse from cancer cells through nor-
mal cells in the tumour periphery, without direct contact
to the cancer cells [6]. The peritumoural skin in the
present study was taken often >0.5 cm from the BCC
rendering this mechanism unlikely. We hypothesise, that
chronic UV-exposure partly mediates this induction of
CAFs generating a tumour friendly microenvironment
where neoplastic cells thrive. This could partly be caused
by increased IL6 expression mediated by UV-exposure
[42] since in cutaneous squamous cell carcinoma IL6
has been shown to be tumour-promoting by induction
of CAFs [43]. In our study, we found a high expression
of IL6 in the peritumoural skin, whereas IL6 was almost
absent within BCC and completely absent in the non-
UV-exposed buttock skin. This highly increased expres-
sion of IL6 in the tumour periphery might be a result of
chronic UV exposure contributing to the shift in
fibroblast phenotype. Regardless of whether CAFs in the
peritumoural skin are induced by long-term UV-induced
immunosuppression or by the neoplastic BCC cells,
peritumoural CAFs could mediate an environment
susceptible to skin cancer development or recurrence.
Conclusion
In summary, we have shown features of matrix remodeling
in BCC. Furthermore, we found that CAFs are abundant in
BCC and may impact anti-tumour response by secretion of
pro-carcinogenic cytokines and chemokines. Peritumoural
skin also contains active, chemokine-secreting CAFs which
could mediate an environment susceptible to skin cancer
development or recurrence. However, further functional
studies are needed to clarify the role of CAFs in BCC.
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